Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

183.80 +13.53 (+7.95%)
Streaming Delayed Price Updated: 9:33 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 533,885
Open 185.20
Bid (Size) 183.10 (200)
Ask (Size) 184.50 (300)
Prev. Close 170.27
Today's Range 180.87 - 186.19
52wk Range 60.40 - 212.75
Shares Outstanding 115,246,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗
Investors today are cheering envudeucitinib's Phase 3 edge in oral TYK2 psoriasis as well as Alumis' plans to raise fresh capital. 
Via The Motley Fool
Topics Stocks
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
+3.8%
+3.8%
1 Month
-5.3%
-5.3%
3 Month
+11.8%
+11.8%
6 Month
+90.2%
+90.2%
1 Year
+179.7%
+179.7%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
From Pomerantz LLP
Via GlobeNewswire
News headline image
Earnings Scheduled For October 30, 2025 ↗
Via Benzinga
News headline image
A Preview Of Insmed's Earnings ↗
Via Benzinga
News headline image
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗
Via Stocktwits
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
Via MarketMinute
News headline image
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
Billionaire Stanley Druckenmiller Just Bet Big on This Hot IPO Stock. Is It a Buy? ↗
Via The Motley Fool
Topics ETFs Initial Public Offering Regulatory Compliance
News headline image
Peering Into Insmed Inc's Recent Short Interest ↗
Via Benzinga
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
Via Benzinga
News headline image
If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today ↗
Via Benzinga
News headline image
This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗
Via Investor's Business Daily
News headline image
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗
Via Benzinga
Topics Economy

Frequently Asked Questions

Is Insmed Incorporated - Common Stock publicly traded?
Yes, Insmed Incorporated - Common Stock is publicly traded.
What exchange does Insmed Incorporated - Common Stock trade on?
Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insmed Incorporated - Common Stock?
The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
What is the current price of Insmed Incorporated - Common Stock?
The current price of Insmed Incorporated - Common Stock is 183.80
When was Insmed Incorporated - Common Stock last traded?
The last trade of Insmed Incorporated - Common Stock was at 01/09/26 09:33 AM ET
What is the market capitalization of Insmed Incorporated - Common Stock?
The market capitalization of Insmed Incorporated - Common Stock is 21.18B
How many shares of Insmed Incorporated - Common Stock are outstanding?
Insmed Incorporated - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.